These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19875388)

  • 1. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.
    Romeyer-Bouchard C; Da Costa A; Dauphinot V; Messier M; Bisch L; Samuel B; Lafond P; Ricci P; Isaaz K
    Eur Heart J; 2010 Jan; 31(2):203-10. PubMed ID: 19875388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection.
    Seifert M; Moeller V; Arya A; Schau T; Hoelschermann F; Butter C
    Europace; 2018 May; 20(5):808-815. PubMed ID: 28398556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular lead implantation at a phrenic stimulation site is safe and effective.
    Jastrzebski M; Bacior B; Wojciechowska W; Czarnecka D
    Europace; 2011 Apr; 13(4):520-5. PubMed ID: 21242156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac implantable electronic device infections: Who is at greatest risk?
    Joy PS; Kumar G; Poole JE; London B; Olshansky B
    Heart Rhythm; 2017 Jun; 14(6):839-845. PubMed ID: 28315744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure.
    De Sutter J; Weytjens C; Van de Veire N; Provenier F; Vande Kerckhove B; Willems AM; De Laet N; Van Camp G
    Eur J Heart Fail; 2011 Apr; 13(4):412-5. PubMed ID: 21138909
    [No Abstract]   [Full Text] [Related]  

  • 8. Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome.
    Ajijola OA; Macklin EA; Moore SA; McCarty D; Bischoff KE; Heist EK; Picard M; Ruskin JN; Dec GW; Singh JP
    Europace; 2010 Dec; 12(12):1745-9. PubMed ID: 20852289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing operator radiation exposure during cardiac resynchronization therapy.
    Brambilla M; Occhetta E; Ronconi M; Plebani L; Carriero A; Marino P
    Europace; 2010 Dec; 12(12):1769-73. PubMed ID: 21097481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening heart failure as the main manifestation of neglected complete extrusion of a cardiac resynchronization therapy pacemaker.
    Vassilikos VP; Mantziari AA; Stavropoulos G; Styliadis IH
    Cardiology; 2010; 117(4):243-5. PubMed ID: 21228592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.
    Cano O; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Europace; 2011 Mar; 13(3):395-401. PubMed ID: 21131650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.
    Uslan DZ; Dowsley TF; Sohail MR; Hayes DL; Friedman PA; Wilson WR; Steckelberg JM; Baddour LM
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):407-13. PubMed ID: 19793360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of cephalic venous access for cardiac resynchronization device implantation.
    Ussen B; Dhillon PS; Anderson L; Beeton I; Hickman M; Gallagher MM
    Pacing Clin Electrophysiol; 2011 Mar; 34(3):365-9. PubMed ID: 21091741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iterative cardiac output measurement for optimizing cardiac resynchronization therapy: a randomized, blinded, crossover study.
    Reinsch N; Konorza T; Woydowski D; Bruck H; Volsek M; Müller-Tasch T; Neumann T; Erbel R; Wieneke H
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1188-94. PubMed ID: 20663072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999.
    Cabell CH; Heidenreich PA; Chu VH; Moore CM; Stryjewski ME; Corey GR; Fowler VG
    Am Heart J; 2004 Apr; 147(4):582-6. PubMed ID: 15077071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus.
    Greenspon AJ; Rhim ES; Mark G; Desimone J; Ho RT
    Pacing Clin Electrophysiol; 2008 May; 31(5):548-53. PubMed ID: 18439167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.
    Voigt A; Shalaby A; Saba S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):414-9. PubMed ID: 19793359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial.
    Durante A; Cianflone D; Camici PG
    J Am Coll Cardiol; 2011 Jul; 58(4):442-3; author reply 443-4. PubMed ID: 21757127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.